Executive summary

This study reported results of 25 patients with localized nonresectable pancreatic cancer (15 patients) or local recurrent disease (10 patients) treated with chemoradiation using PBT. The median progression-free survival was 5.9 months and median overall survival was 11.0 months. Four grade 3 and 4 acute adverse events were reported. 

Key content topics